2020
Pettitt, A. R., Jackson, R., Cicconi, S., Polydoros, F., Yap, C., Dodd, J., . . . Hillmen, P. (2020). Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.. Haematologica, 105(12), 2868-2871. doi:10.3324/haematol.2019.230805DOI: 10.3324/haematol.2019.230805
Whittam, D. H., Cobo-Calvo, A., Lopez-Chiriboga, A. S., Pardo, S., Gornall, M., Cicconi, S., . . . Jacob, A. (2020). Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.. Multiple sclerosis and related disorders, 44. doi:10.1016/j.msard.2020.102251DOI: 10.1016/j.msard.2020.102251
Castle, J., Blower, E., Bundred, N. J., Harvey, J. R., Thachil, J., Marshall, A., . . . Kirwan, C. C. (2020). Rivaroxaban compared to no treatment in ER-negative stage I-III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial. TRIALS, 21(1). doi:10.1186/s13063-020-04675-7DOI: 10.1186/s13063-020-04675-7
ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer. (Conference Paper)
Ghaneh, P., Palmer, D. H., Cicconi, S., Halloran, C., Psarelli, E. E., Rawcliffe, C. L., . . . Neoptolemos, J. P. (2020). ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.. In Journal of Clinical Oncology Vol. 38 (pp. 4505). American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2020.38.15_suppl.4505DOI: 10.1200/jco.2020.38.15_suppl.4505
Gottschalk, A., Glauche, I., Cicconi, S., Clark, R. E., & Roeder, I. (2020). Molecular dynamics during reduction of TKI dose reliably identify molecular recurrence after treatment cessation in CML.. Blood. doi:10.1182/blood.2019003395DOI: 10.1182/blood.2019003395
Pettitt, A. R., Jackson, R., Cicconi, S., Polydoros, F., Yap, C., Dodd, J., . . . Hillmen, P. (2020). Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial. HAEMATOLOGICA, 105(12), 2868-2871. doi:10.3324/haematol.2019.230805DOI: 10.3324/haematol.2019.230805
2019
Cicconi, S., Ghaneh, P., Neoptolemos, J., Kolamunnage-Dona, R., & Jackson, R. (2019). Joint Modelling for longitudinal measures of marker CA19-9 and survival data in patients with pancreatic cancer. In TRIALS Vol. 20. Retrieved from https://www.webofscience.com/
BRIEF CO‐ADMINISTRATION OF IDELALISIB MAY IMPROVE THE LONG‐TERM EFFICACY OF FRONTLINE CHEMOIMMUNOTHERAPY IN CHRONIC LYMPHOCYTIC LEUKAEMIA: 3‐YEAR FOLLOW‐UP FROM THE RIALTO TRIAL (Conference Paper)
Pettitt, A., Kalakonda, N., Cicconi, S., Murphy, C., Menon, G., Coupland, S. E., . . . Hillmen, P. (2019). BRIEF CO‐ADMINISTRATION OF IDELALISIB MAY IMPROVE THE LONG‐TERM EFFICACY OF FRONTLINE CHEMOIMMUNOTHERAPY IN CHRONIC LYMPHOCYTIC LEUKAEMIA: 3‐YEAR FOLLOW‐UP FROM THE RIALTO TRIAL. In Hematological Oncology Vol. 37 (pp. 217-218). Wiley. doi:10.1002/hon.32_2630DOI: 10.1002/hon.32_2630
Real-world data regarding the efficacy of neoadjuvant carboplatin-paclitaxel followed by dose-dense adriamycin-cyclophosphamide for triple-negative early breast cancer. (Conference Paper)
Bhojwani, A. A., Flint, H., Hall, B. J., Wong, H., Innes, H., Cliff, J., . . . Palmieri, C. (2019). Real-world data regarding the efficacy of neoadjuvant carboplatin-paclitaxel followed by dose-dense adriamycin-cyclophosphamide for triple-negative early breast cancer.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 37. doi:10.1200/JCO.2019.37.15_suppl.e12559DOI: 10.1200/JCO.2019.37.15_suppl.e12559
Real-world evidence regarding the efficacy and toxicity of neoadjuvant trastuzumab and pertuzumab in the management of HER2-positive early-breast cancer. (Conference Paper)
Hall, B. J., Bhojwani, A. A., Innes, H., Ahmed, E., Cliff, J., Malik, Z., . . . Palmieri, C. (2019). Real-world evidence regarding the efficacy and toxicity of neoadjuvant trastuzumab and pertuzumab in the management of HER2-positive early-breast cancer.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 37. doi:10.1200/JCO.2019.37.15_suppl.e12108DOI: 10.1200/JCO.2019.37.15_suppl.e12108
Saunders, R., Ramesh, J., Cicconi, S., Evans, J., Yip, V. S., Raraty, M., . . . Halloran, C. (2019). A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 33(5), 1412-1425. doi:10.1007/s00464-018-6416-5DOI: 10.1007/s00464-018-6416-5
Mann, K., Gilbert, T., Cicconi, S., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2019). Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. LANGENBECKS ARCHIVES OF SURGERY, 404(4), 439-449. doi:10.1007/s00423-019-01779-wDOI: 10.1007/s00423-019-01779-w
Olsson-Brown, A., Piskilidis, P., O'Hagan, J., Thorp, N., Robson, P., Innes, H., . . . Palmieri, C. (2019). The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool. BREAST, 44, 94-100. doi:10.1016/j.breast.2019.01.005DOI: 10.1016/j.breast.2019.01.005
Profiling the early haematological dynamics and treatment modifications with palbociclib when used as first line treatment for ER-positive, HER2-negative metastatic breast cancer (Conference Paper)
Bhojwani, A., Flint, H., Hall, B., Wong, H., Innes, H., Cliff, J., . . . Palmieri, C. (2019). Profiling the early haematological dynamics and treatment modifications with palbociclib when used as first line treatment for ER-positive, HER2-negative metastatic breast cancer. In CANCER RESEARCH Vol. 79. doi:10.1158/1538-7445.SABCS18-P6-18-32DOI: 10.1158/1538-7445.SABCS18-P6-18-32
Real world experience of the medical and surgical management of HER2 positive early breast cancer treated with neoadjuvant trastuzumab and pertuzumab via the NHS England cancer drug fund (Conference Paper)
Hall, B., Bhojwani, A., Innes, H., Ahmed, E., Cliff, J., Malik, Z., . . . Palmieri, C. (2019). Real world experience of the medical and surgical management of HER2 positive early breast cancer treated with neoadjuvant trastuzumab and pertuzumab via the NHS England cancer drug fund. In CANCER RESEARCH Vol. 79. doi:10.1158/1538-7445.SABCS18-P6-17-27DOI: 10.1158/1538-7445.SABCS18-P6-17-27
Hope, W., Johnstone, G., Cicconi, S., Felton, T., Goodwin, J., Whalley, S., . . . Neely, M. (2019). Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study.. Antimicrobial agents and chemotherapy. doi:10.1128/aac.02353-18DOI: 10.1128/aac.02353-18
Simultaneous resection of primary tumour and liver metastasis for colorectal cancer with synchronous liver metastases: a single centre experience (Conference Paper)
Mann, K., Cicconi, S., Alvarez, L. C., Charnock, A., Skaife, P., Walsh, C., . . . Diaz-Nieto, R. (2019). Simultaneous resection of primary tumour and liver metastasis for colorectal cancer with synchronous liver metastases: a single centre experience. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 15). Retrieved from https://www.webofscience.com/
2017
USAGE OF TRANSMURAL METAL STENTS FOR ENDOSCOPIC ULTRASOUND GUIDED DRAINAGE OF PSEUDOCYSTS MAY LEAD TO LOWER REINTERVENTION RATES (Conference Paper)
Ramesh, J., Saunders, R., Evans, J., Ghaneh, P., Raraty, M., Yip, V., . . . Halloran, C. (2017). USAGE OF TRANSMURAL METAL STENTS FOR ENDOSCOPIC ULTRASOUND GUIDED DRAINAGE OF PSEUDOCYSTS MAY LEAD TO LOWER REINTERVENTION RATES. In GUT Vol. 66 (pp. A276). doi:10.1136/gutjnl-2017-314472.538DOI: 10.1136/gutjnl-2017-314472.538
Usage of transmural metal stents for endoscopic ultrasound guided drainage of pseudocysts may lead to lower reintervention rates (Conference Paper)
Ramesh, J., Saunders, R., Evans, J., Ghaneh, P., Raraty, M., Yip, V., . . . Halloran, C. (2017). Usage of transmural metal stents for endoscopic ultrasound guided drainage of pseudocysts may lead to lower reintervention rates. In BRITISH JOURNAL OF SURGERY Vol. 104 (pp. 27). Retrieved from https://www.webofscience.com/